Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ziejewski MK"'
Autor:
Stokes AH; GSK, Rockville, MD, USA., Franklin K; 201915Covance Laboratories Inc., Greenfield, IN, USA., Fisher DE; Charles River Laboratories, Horsham, PA, USA., Posobiec LM; 33139GSK, Collegeville, PA, USA., Binazon O; 33139GSK, Wavre, Belgium., Tripathi N; 201915Covance Laboratories Inc, Madison, WI, USA., Ringenberg MA; 33139GSK, Collegeville, PA, USA., Charlap J; Charles River Laboratories, Horsham, PA, USA.; Current affiliation: Chevron, San Ramon, CA, USA., Ziejewski MK; 33139GSK, Collegeville, PA, USA., Vemireddi V; 201915Covance Laboratories Inc, Chantilly, VA, USA., Khanna Weiss P; 201915Covance Laboratories Inc, Chantilly, VA, USA.; Current affiliation: DEFTEC Corporation, Inc., Chantilly, VA ,USA., Majumdar R; 201915Covance Laboratories Inc, Chantilly, VA, USA., Bouzya B; 33139GSK, Rixensart, Belgium., Donner MN; 33139GSK, Rixensart, Belgium., Rodriguez LA; 33139GSK, Wavre, Belgium., Baumeister J; 33139GSK, Wavre, Belgium.; Current affiliation: ArgenX, Belgium.
Publikováno v:
International journal of toxicology [Int J Toxicol] 2021 Mar-Apr; Vol. 40 (2), pp. 125-142. Date of Electronic Publication: 2021 Feb 01.
Autor:
Stanislaus DJ; Reproductive Toxicology, In Vitro/In Vivo Translation, GlaxoSmithKline, Upper Providence, Pennsylvania., Posobiec LM; Reproductive Toxicology, In Vitro/In Vivo Translation, GlaxoSmithKline, Upper Providence, Pennsylvania., Laffan SB; Reproductive Toxicology, In Vitro/In Vivo Translation, GlaxoSmithKline, Upper Providence, Pennsylvania., Solomon HM; Reproductive Toxicology, In Vitro/In Vivo Translation, GlaxoSmithKline, Upper Providence, Pennsylvania., Ziejewski MK; Reproductive Toxicology, In Vitro/In Vivo Translation, GlaxoSmithKline, Upper Providence, Pennsylvania., Romach EH; Non-Clinical Safety, Research & Development, Viiv Healthcare, Research Triangle Park, North Carolina.
Publikováno v:
Birth defects research [Birth Defects Res] 2020 Feb 01; Vol. 112 (3), pp. 245-261. Date of Electronic Publication: 2019 Dec 20.
Autor:
Picut CA; Charles River Laboratories, Pathology Associates, Durham, North Carolina., Ziejewski MK; GlaxoSmithKline Research & Development, King of Prussia, Pennsylvania., Stanislaus D; GlaxoSmithKline Research & Development, King of Prussia, Pennsylvania.
Publikováno v:
Birth defects research [Birth Defects Res] 2018 Feb 15; Vol. 110 (3), pp. 190-227. Date of Electronic Publication: 2017 Oct 24.
Autor:
Ziejewski MK; Department of Reproductive and Developmental Toxicology, GlaxoSmithKline Research & Development, King of Prussia, Pennsylvania., Solomon HM, Rendemonti J, Stanislaus D
Publikováno v:
Birth defects research. Part B, Developmental and reproductive toxicology [Birth Defects Res B Dev Reprod Toxicol] 2015 Feb; Vol. 104 (1), pp. 23-34. Date of Electronic Publication: 2015 Feb 21.
Autor:
Ziejewski MK; Department of Safety Assessment, Reproductive and Developmental Toxicology, GlaxoSmithKline Research & Development, King of Prussia, PA 19406, USA., Vidal JD, Stanislaus D, Apostoli A, Chowdhury P, Laffan S
Publikováno v:
Birth defects research. Part B, Developmental and reproductive toxicology [Birth Defects Res B Dev Reprod Toxicol] 2013 Feb; Vol. 98 (1), pp. 63-71. Date of Electronic Publication: 2013 Jan 24.
Autor:
Ziejewski MK; Department of Reproductive and Developmental Toxicology, GlaxoSmithKline Research & Development, King of Prussia, Pennsylvania 19406, USA. mary.k.ziejewski@gsk.com, Solomon HM, Stanislaus D, Clark RL, White TE, Apostoli AR
Publikováno v:
Birth defects research. Part B, Developmental and reproductive toxicology [Birth Defects Res B Dev Reprod Toxicol] 2012 Feb; Vol. 95 (1), pp. 54-62. Date of Electronic Publication: 2011 Nov 29.